Translational Research
-
Safety And Efficacy Advancements In Genome Editing
11/9/2024
Paul Kopesky, Ph.D., VP of Cell Therapy Process Development at Beam Therapeutics shares his take on the high frequency of productive edits for base editing. In addition, Celularity’s Chairman, Founder, and CEO, Dr. Robert Hariri, shares how he sees non-viral gene delivery methods potentially enhancing cell therapy platforms.
-
Validation Of An LCMS Hybrid Assay With EVOSEP Cleanup
2/17/2025
By leveraging this innovative combination, the assay achieves detection limits comparable to traditional methodologies while enhancing overall efficiency and reliability.
-
Real-Time Monitoring And Automated Sampling For Enhanced Efficiency
3/17/2025
Integrating real-time, in-line monitoring with automated sampling in bioprocessing enhances efficiency and precision. Discover how advanced spectroscopy provides non-destructive insights to optimize cell growth and productivity.
-
Can Kinetics Provide Detailed Information About Binding Interactions?
2/17/2022
See the potential value kinetics brings to deepen the understanding of biological processes.
-
Plasmid Complexity And The Push For Stronger CGT Material Control
4/1/2026
In this segment of Cell & Gene Live, Anthony Blaszczyk, Ph.D., Senior Scientist at the U.S. Pharmacopeia, and Basak Clements, Ph.D., Founder and Senior Advisor at biomatria, were joined by Cell & Gene Chief Editor Erin Harris to discuss why complex materials such as plasmid DNA are critical yet challenging in cell and gene therapy because small variations (e.g., sequence or structure) can significantly impact the final product, and current analytical tools often struggle to fully characterize them.
-
High Efficiency Cell Engineering From Concept To Clinic
4/21/2025
Discover how highly efficient and scalable methods for engineering cells are accelerating the development and delivery of next-generation cell-based treatments for patients.
-
GLP And The Impact To Start Up Companies
4/18/2022
Good Laboratory Practice is often used in laboratories and is necessary for specific investigations. What does it mean? And how can it help start-up companies? Watch this video to learn more.
-
Major Advancements In mRNA
1/29/2024
Experts on this Cell & Gene live event discuss the major scientific biological advances in understanding the potential for mRNA-based immunotherapies vaccines for cancer over the last 2 years.
-
Using ddPCR Technology To Characterize The Poly(A) Tail Content
7/27/2023
When characterizing 3’ poly(A) tail length and integrity, Droplet Digital PCR technology demonstrates an orthogonal or alternative method to help ensure the quality and consistency of mRNA products.
-
Early-Phase Whole-Body PK
4/21/2025
Accelerate your path to the clinic with Aliri’s cost-effective, label-free whole-body PK service — designed to deliver deeper insights, faster decisions, and better outcomes for your drug candidates.